Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Cell Death & Disease
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. cell death & disease
  3. articles
  4. article
PHF20 stabilizes the GAS7-F-actin axis to drive DNA damage repair and chemoresistance in cutaneous squamous cell carcinoma
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 29 May 2026

PHF20 stabilizes the GAS7-F-actin axis to drive DNA damage repair and chemoresistance in cutaneous squamous cell carcinoma

  • Yunqian Li  ORCID: orcid.org/0009-0005-4279-44131,2 na1,
  • He Wen1 na1,
  • Han Zheng3,
  • Yunyue Zhen  ORCID: orcid.org/0000-0002-3786-29021,2,
  • Jing Jia4 &
  • …
  • Zhengjun Li1 

Cell Death & Disease (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Oncogenes
  • Squamous cell carcinoma

Abstract

Cutaneous squamous cell carcinoma (cSCC) is a common and aggressive skin cancer, with treatment options for advanced stages often limited by chemoresistance. Here, we observe a positive correlation between PHF20 expression and the malignancy and tumor grade of cSCC. Functional studies suggest that PHF20 promotes oncogenic phenotypes, including proliferation, invasion, and epithelial-mesenchymal transition. Notably, PHF20 depletion appears to sensitize cSCC cells to chemotherapeutic agents. Mechanistically, we show that PHF20 interacts with and promotes the ubiquitin-mediated degradation of GAS7. This downregulation of GAS7 is associated with nuclear F-actin assembly, a process that has been implicated in DNA damage repair (DDR). Consequently, PHF20 loss stabilizes GAS7, enhances nuclear F-actin assembly, and is accompanied by increased DNA damage accumulation. These in vitro findings were corroborated in vivo, where PHF20 knockdown suppressed tumor growth and increased DNA damage. Together, PHF20 may contribute to the regulation of DDR and chemotherapeutic response, highlighting its potential as a therapeutic target in poorly differentiated cSCC.

The alternative text for this image may have been generated using AI.

Acknowledgements

We thank the Research Center for Basic Medical Science of Qilu Hospital, affiliated to Shandong University, for consultation and instrument availability that supported this work. This project was supported by the National Natural Science Foundation of China (26010105131642) and China Postdoctoral Science Foundation (21510072310038).

Author information

Author notes
  1. These authors contributed equally: Yunqian Li, He Wen.

Authors and Affiliations

  1. Department of Dermatology, Qilu Hospital of Shandong University, Jinan, Shandong, China

    Yunqian Li, He Wen, Yunyue Zhen & Zhengjun Li

  2. Laboratory of Basic Medical Science, Qilu Hospital of Shandong University, Jinan, Shandong, China

    Yunqian Li & Yunyue Zhen

  3. Department of Orthopedics, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China

    Han Zheng

  4. Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China

    Jing Jia

Authors
  1. Yunqian Li
    View author publications

    Search author on:PubMed Google Scholar

  2. He Wen
    View author publications

    Search author on:PubMed Google Scholar

  3. Han Zheng
    View author publications

    Search author on:PubMed Google Scholar

  4. Yunyue Zhen
    View author publications

    Search author on:PubMed Google Scholar

  5. Jing Jia
    View author publications

    Search author on:PubMed Google Scholar

  6. Zhengjun Li
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Jing Jia or Zhengjun Li.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Professor Francesca Pentimalli

Supplementary information

Supplementary information (download DOCX )

checklist (download PDF )

Original western blots (download PDF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Wen, H., Zheng, H. et al. PHF20 stabilizes the GAS7-F-actin axis to drive DNA damage repair and chemoresistance in cutaneous squamous cell carcinoma. Cell Death Dis (2026). https://doi.org/10.1038/s41419-026-08932-6

Download citation

  • Received: 25 September 2025

  • Revised: 01 May 2026

  • Accepted: 22 May 2026

  • Published: 29 May 2026

  • DOI: https://doi.org/10.1038/s41419-026-08932-6

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • About the Editors
  • Open access publishing
  • Contact
  • For Advertisers
  • Press Releases
  • About the Partner
  • Upcoming Conferences

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Cell Death & Disease (Cell Death Dis)

ISSN 2041-4889 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited